Country: United States
Language: English
Source: NLM (National Library of Medicine)
DILTIAZEM HYDROCHLORIDE (UNII: OLH94387TE) (DILTIAZEM - UNII:EE92BBP03H)
St Marys Medical Park Pharmacy
DILTIAZEM HYDROCHLORIDE
DILTIAZEM HYDROCHLORIDE 240 mg
PRESCRIPTION DRUG
Abbreviated New Drug Application
DILTIAZEM HYDROCHLORIDE - DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE ST MARYS MEDICAL PARK PHARMACY ---------- DESCRIPTION Diltiazem is a calcium ion influx inhibitor (slow channel blocker or calcium antagonist). Chemically, diltiazem hydrochloride is 1,5-Benzothiazepin-4(5H)one,3-(acetyloxy)-5-[2-(dimethylamino) ethyl]-2,3- dihydro-2-(4-methoxyphenyl)-, monohydrochloride, (+)-cis-. Its molecular formula is C22H26N2O4S HCl and its molecular weight is 450.99. Its structural formula is as follows: Diltiazem hydrochloride, USP is a white to off-white crystalline powder with a bitter taste. It is soluble in water, methanol and chloroform. Diltiazem Hydrochloride Extended-release Capsules, USP (Once-a-Day Dosage), for oral administration, contain multiple units of diltiazem hydrochloride extended-release 60 mg, resulting in the 120 mg, 180 mg or 240 mg dosage strengths allowing for the controlled release of diltiazem hydrochloride over a 24-hour period. In addition, each capsule contains the following inactive ingredients: ammonium hydroxide, colloidal silicon dioxide, dibutyl sebacate, ethylcellulose, hypromellose, magnesium stearate, maltodextrin, microcrystalline cellulose, oleic acid, polyethylene glycol and sodium lauryl sulfate. The empty hard-shell gelatin capsules contain FDandC Blue No. 1, FDandC Red No. 40 Aluminum Lake, gelatin, sodium lauryl sulfate and titanium dioxide. In addition, the 120 mg and 180 mg empty hard-shell gelatin capsules contain DandC Red No. 28. The imprinting ink contains black iron oxide, DandC Yellow No. 10 Aluminum Lake, FDandC Blue No. 1 Aluminum Lake, FDandC Blue No. 2 Aluminum Lake, FDandC Red No. 40 Aluminum Lake, propylene glycol and shellac glaze. Diltiazem Hydrochloride Extended-release Capsules, USP (Once-a-Day Dosage) 120 mg, 180 mg and 240 mg meet USP Drug Release Test 8. CLINICAL PHARMACOLOGY The therapeutic benefits of diltiazem are believed to be related to its ability to inhibit the influx of calcium ions during membrane depolarization of cardiac and vascular smo Read the complete document